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Abstract 
Bromocriptine, a dopamine agonist, is now an accepted primary therapeutic agent for patients with prolactinomas and other pituitary adenomas. 
In this study, we demonstrated that bromocriptine inhibited the proliferation of murine ACTH-secreting pituitary adenoma (AtT-20) cells. In addition, 
the antitumor activity of bromocriptine was inhibited both by actinomycin D and cycloheximide, suggesting that it was dependent on new RNA and 
protein synthesis. Interestingly, the results of DNA fragmentation assays and cell cycle analysis clearly demonstrated that bromocriptine induced 
apoptosis in AtT-20 cells. 
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1. Introduction 
Apoptosis (programmed cell death) [l] can be de- 
scribed as a process in which cells actively participate in 
their own death. The term apoptosis has been used to 
describe the death of cells killed during normal develop- 
ment or by growth factor deprivation [2-4 Apoptotic 
dying cells exhibit characteristic hanges, including chro- 
matin condensation, membrane blebbing, and fragmen- 
tation of the DNA into nucleosome-sized pieces. The 
DNA fragmentation which occurs yields a ladder pattern 
in agarose gel and is a hallmark of apoptotic cell death. 
Recently, apoptosis has also been the focus of research 
since it can result from the administration of antitumor 
chemotherapeutic drugs such as camptothecin [5], cis- 
platin [6] and etoposide [7]. 
Bromocriptine, a dopamine agonist, is now an ac- 
cepted therapeutic agent for patients with prolactino- 
mas, GH-secreting pituitary adenomas [8-121, and 
ACTH-secreting pituitary adenomas [131. Bromocriptine 
decreases elevated serum level of prolactin or growth 
hormone and shrinks such tumors by diminishing tumor 
cell size. Ultrastructural studies following bromocriptine 
administration demonstrate nuclear pyknosis, aggre- 
gated chromatin, reduced volume densities of rough en- 
doplasmic reticulum and Golgi apparatus, a significant 
reduction in the volume of the cytoplasma, and atrophy 
*Corresponding author. 
Abbreviations: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra- 
solium bromide; PBS, phosphate-buffered saline. 
or swelling of mitochondria [14-161. The above findings 
and those of other biochemical studies together make 
clear that bromocriptine inhibits hormone and DNA 
biosynthesis [17,181 and has antimitotic effects [19,20]. 
However, the mechanisms by which bromocriptine in- 
hibits growth are not yet known in detail. In this study, 
therefore, we used a DNA fragmentation assay and cell 
cycle analysis in attempting to determine whether bro- 
mocriptine induces apoptosis in murine ACTH-secreting 
pituitary adenoma (AtT-20) cells. 
2. Materials and methods 
2.1. Materials 
2.1.1. Chemotherapeutrc agent. Bromocriptine was the generous gift 
of Sandoz Pharmaceutical Co., Ltd. (Tokyo, Japan). It was obtained 
in powder form, from which a 10 mM stock solution was prepared in 
methanol. 
2.1.2. Cells. Murine ACTH-secreting pituitary tumor (AtT-20) cells 
were kindly provided by the Japanese Cancer Research Resources Bank 
(Tokyo, Japan). AtT-20 cells were maintained in suspension culture in 
Ham’s FlO containing glutamine, 15% horse serum, 2.5% fetal calf 
serum, and the antibiotics penicillin and streptomycin. 
2.2. Methods 
2.2.1. Cell viability. The cytotoxic effects of bromocriptine on AtT- 
20 cells were quantified using a modified MTT (CHEMICON, Teme- 
cula, CA) calorimetric assay [21]. Cells were seeded at lo4 cells/ well (0.1 
ml) in 96-well flat-bottomed plates (Corning, NY) and treated with 
varying doses of bromocriptine between 0.1 pg/ml and 40 pg/ml. Fol- 
lowing a 72-h period of incubation at 37”C, 0.01 ml of MTT reagent 
was added to each well. Following another 4-h period of incubation at 
37”C, 0.1 ml of isopropanol with 0.04 N HCl was added to each well 
to dissolve precipitates, and absorbance was then measured at 570 nm 
with an autoreader (ER-8000, Sanko Junyaku Co., Ltd., Tokyo, Japan) 
within 30 min of dissolution. 
2.2.2 Inhibition of RNA andprotein synthesis. To determine whether 
inhibition of RNA or protein synthesis results in inhibition of the 
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cytotoxicity induced by bromocriptine, AtT-20 cells were pretreated for 
5 min with actinomycin D (40 @ml) to inhibit RNA synthesis or 
cycloheximide (0.4 &ml) to inhibit protein synthesis, prior to chemo- 
therapy. Changes induced in cytotoxicity were then quantified using a 
modified MTT assay. 
2.2.3. Analysis of DNA fragmentation in agarose gels. This assay was 
performed using methods previously described [22]. Briefly, harvested 
cells (1 x 107) were centrifuged and washed twice with cold PBS. The 
cell pellet was lysed in 1.0 ml of a buffer consisting of 10 mM Tris-HCl, 
10 mM EDTA and 0.2% Triton X-100 (pH 7.5). After 10 min on ice, 
the lysate was centrifuged (13,000 x g) for 10 min at 4°C in an Eppen- 
dorf microfuge. Then, the supernatant (containing RNA and frag- 
mented DNA, but not intact chromatin) was extracted first with phenol 
and then with phenol-chloroform/isoamyl alcohol (24 : 1). The aqueous 
phase was brought to 300 mM NaCl and nucleic acids were precipitated 
with 2 vol of ethanol. The pellet was rinsed with 70% ethanol, air-dried 
and then dissolved in 20~1 of 10 mM Tris-HCI, 1 mM EDTA (pH 7.5). 
Following digestion of RNA with RNase A (0.6 mg/ml, at 37°C for 30 
min), the sample was electrophoresed ina 2% agarose gel with Boyer’s 
buffer (50 mM Tris-HCl, 20 mM sodium acetate, 2 mM EDTA and 18 
mM NaCl, pH 8.05). DNA was then visualized with ethidium bromide 
staining. 
2.2.4. Flop cytometry. AtT-20 cells were treated with 10 pg/rnl bro- 
mocrintine for 72 h. Then 2 x lo6 cells were fixed with 2 ml of 70% 
ethanol on ice for 15 min, and pelleted and stained with propidium 
iodide (50 pg/rnl in PBS) containing 0.5 mg/ml RNase A for an addi- 
tional 30 min on ice prior to analysis of DNA content by flow cytom- 
etry. Cells were tested for cell cycle position using a FACScan flow 
cytometer (Becton Dickinson, Mountam View, CA) equipped with 
CellFIT version 2.0 software. The SOBR (Sum of Broadened Rectan- 
gles) model provided by this software was used to estimate the percent- 
age of cells in each phase of the cell cycle. This model uses a complex 
repetitive calculation to produce approximations to the actual histo- 
gram, fitting GO/G1 and G2/M populations with single Gaussian 
curves. 
3. Results and discussion 
Pituitary adenomas, particularly prolactinomas, are 
not rare. The reported incidence of microadenomas var- 
ies between 23% and 27% [23]. The goals of therapy for 
pituitary adenomas always include reduction of tumor 
mass, restoration of normal visual field and cranial nerve 
function, preservation of other anterior pituitary func- 
tions, suppression of excessive hormone secretion, and 
prevention of recurrence or progression of the disease. 
Bromocriptine has been used not only for treatment of 
mild hyperprolactinemia nd microadenomas but also as 
initial therapy for large prolactinomas and persistent 
postoperative hyperprolactinemia. There have been 
many reports of its efficacy in lowering serum prolactin 
level, reducing tumor size, improving visual field abnor- 
malities, and restoring gonadal function. However, it is 
not yet clear how bromocriptine exerts its antitumor 
effects on pituitary adenomas. As shown in Fig. 1, bro- 
mocriptine inhibited the proliferation of AtT-20 cells in 
a dose-dependent fashion. In addition, the decrease in 
AtT-20 cell viability induced by bromocriptine is almost 
entirely dependent on RNA and protein synthesis, since 
actinomycin D and cycloheximide each prevent cell 
death in part. These findings demonstrate that bro- 
mocriptine can kill pituitary tumor cells in vitro, and that 
RNA and protein synthesis are required for the induc- 
tion of cell death by bromocriptine. 
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Fig. 1. The effects of various doses of bromocriptine on AtT-20 cells, 
and the degree of inhibition of cytotoxicity induced by actinomycin D 
and cycloheximide, as determined using a modified MTT assay after 
72 h treatment. Bromocriptine inhibited the proliferation of AtT-20 
cells in a dose-dependent fashion (Q). Actinomycin D (40 @ml, A) and 
cycloheximide (0.4&ml, A) each partially prevented the loss of AtT-20 
cell viability induced by bromocriptine. Values represent the 
mean f S.D. of results of three experiments. 
Apoptosis is characterized by cell shrinkage, and also 
by DNA fragmentation due to the activation of an 
uncharacterized Ca”/Mg2’ endonuclease which cleaves 
the cell’s DNA into nucleosome-sized units [24,25]. In 
this study, we also attempted to determine whether bro- 
mocriptine induces apoptosis in AtT-20 cells. Our find- 
ings show that DNA fragmentation was clearly induced 
in AtT-20 cells after treatment for 72 h with bro- 
mocriptine (Fig. 2). 
We also studied the changes in the intensity of fluores- 
cence of DNA using flow cytometry. As shown in Fig. 
3, bromocriptine treatment of AtT-20 cells resulted in a 
decrease in the percentage of cells in GO/G1 phase and 
an increase in percentage of cells in S and G2/M phases, 
12 3 4 
Fig. 2. Induction of DNA fragmentation by bromocriptine. Frag- 
mented DNA was isolated after 72 h and electrophoresed m a 2.0% 
agarose gel containing 0.5 &ml ethidium bromide. Molecular weight 
standards of multiples of 123 bp DNA Ladder (GIBCO BRL, Tokyo) 
are shown in lane 1. AtT-20 cells were treated without (lane 2: control) 
or with bromocrtptine (lane 3: 10 &ml; lane 4: 40 &ml). 
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